About Glycoprotein endo-alpha-1,2-mannosidase
Glycoprotein endo-alpha-1,2-mannosidase (MANEA) is a protein
from Homo sapiens identified by UniProt accession
Q5SRI9, 462 residues long.
MolForge cross-references it against 0 known binders and
60 disease associations.
Target properties
| Protein name | Glycoprotein endo-alpha-1,2-mannosidase |
| UniProt accession | Q5SRI9 |
| Gene | MANEA |
| Organism | Homo sapiens |
| Length | 462 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (60)
Diseases linked to this target (Open Targets).
- aspartate aminotransferase measurement · score 0.37
- sex hormone-binding globulin measurement · score 0.33
- blood protein measurement · score 0.29
- arterial stiffness measurement · score 0.05
- infection · score 0.04
- infect · score 0.04
- neoplasm · score 0.03
- social anxiety disorder · score 0.02
- panic disorder · score 0.02
- Acute hepatic failure · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5SRI9-F1 | alphafold | PREDICTED | 86.45 | — |
Amino-acid sequence (462 residues)
MAKFRRRTCI ILALFILFIF SLMMGLKMLR PNTATFGAPF GLDLLPELHQ RTIHLGKNFD FQKSDRINSE TNTKNLKSVE ITMKPSKASE LNLDELPPLN NYLHVFYYSW YGNPQFDGKY IHWNHPVLEH WDPRIAKNYP QGRHNPPDDI GSSFYPELGS YSSRDPSVIE THMRQMRSAS IGVLALSWYP PDVNDENGEP TDNLVPTILD KAHKYNLKVT FHIEPYSNRD DQNMYKNVKY IIDKYGNHPA FYRYKTKTGN ALPMFYVYDS YITKPEKWAN LLTTSGSRSI RNSPYDGLFI ALLVEEKHKY DILQSGFDGI YTYFATNGFT YGSSHQNWAS LKLFCDKYNL IFIPSVGPGY IDTSIRPWNT QNTRNRINGK YYEIGLSAAL QTRPSLISIT SFNEWHEGTQ IEKAVPKRTS NTVYLDYRPH KPGLYLELTR KWSEKYSKER ATYALDRQLP VS
Explore Glycoprotein endo-alpha-1,2-mannosidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets